Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.


TSX:DHT.UN - Post by User

Comment by deleuze68on Apr 27, 2023 11:50am
136 Views
Post# 35417127

RE:RE:Big News

RE:RE:Big NewsI don't think the market fully understands how significant this deal is. They essentially added CAD$3.96 (half their market cap) to the NAV in a span of less than 2 months. 18% (or CAD0.72) of this will be returned to shareholders and the rest will be deployed in new deals. 

The stock has traded at a significant discount to NAV (about 40%) for the last couple of years so taking the $0.72 dividend and adding 60% of the remaining $3.96 gives $2.66. At minimum this should be trading $2.66 higher today. But I think this still is a ridiculously low valuation as this deal proves the ability of the DRI team to source out deals with exponental upside. This really should no longer be trading at a discount to NAV and should now be trading closer to CAD$17.
<< Previous
Bullboard Posts
Next >>